Vilprafen used for many diseases caused by susceptible to the infectious agents. But this is especially effective drug for diseases caused by intracellular pathogens infections - chlamydia, mycoplasma and ureaplasma. The sensitivity of these microorganisms have been confirmed in scientific laboratories, where all investigations are carried out on animals. Many doctors believe that more research on the sensitivity to antibiotics in this case is not required.
Features action Wilprafen
Vilprafen - a modern high-performance macrolide antibiotic. Active ingredient in it is Josamycin. Vilprafen produced as tablets or suspensions for oral administration, as well as tablets soljutab - a dosage form that acts faster and more efficient than conventional tablets.
After absorption in the gastrointestinal tract vilprafen first enters into the blood, and then distributed to the tissues. Especially a lot of Wilprafen enters the respiratory tract and ENT-organs, contain 8-9 times more Wilprafen than in blood. Vilprafen can pass through the placenta to the fetus and to stand with human milk. Vilprafen displayed in the bile and feces, after decomposing in the liver to less active metabolites. A small part of it is excreted in the urine.
Once in the tissue, vilprafen in normal therapeutic doses suppress the vital activity of pathogens. Including it penetrates the tissue cells and suppresses the livelihoods of intracellular pathogens such as Chlamydia, Mycoplasma and ureaplasma
This insidious ureaplasma - often too late
. Active vilprafen also against many staphylococci, streptococci, gonococci, meningococci, and other bacteria that cause infectious inflammation of various organs.
In addition, it is active against pathogens of certain infectious diseases - diphtheria, scarlet fever, whooping cough
This pest, pest whooping ...
, Anthrax, erysipelas.
In large doses vilprafen has a bactericidal effect - it kills sensitive bacteria.
Which diseases appoint vilprafen
Vilprafen is often the drug of choice in the treatment of chlamydial, mycoplasma and ureaplasma infections, including in pregnant women. With easy to suppress infections occurring pathogen enough vilprafenom one course of treatment, in more severe or prolonged duration appointed alternate courses of antibiotics and Wilprafen fluoroquinolone or tetracycline. One type of chlamydia
Chlamydia: insidious and widespread disease
called psittacosis or parrot disease (transferred parrots), which is also well treated vilprafenom.
Vilprafen prescribed diseases and sexually transmitted infections, including sexually transmitted diseases at - gonorrhea, syphilis, lymphogranuloma venereum and complications caused by them.
High efficiency manifests vilprafen the treatment of diseases of upper respiratory tract and respiratory system. It is successfully used in the treatment of otitis media, sinusitis, follicular and lacunar angina, exacerbation of chronic tonsillitis
Chronic tonsillitis - inflammation of the tonsils
, Pharyngitis, laryngitis, bronchitis (including chronic) and pneumonia.
Vilprafenom treatable infectious diseases - diphtheria, whooping cough, anthrax. But it is particularly effective against diseases caused by streptococcal infection - scarlet fever and erysipelas.
Apply vilprafen for the treatment of infectious and inflammatory processes in the oral cavity and in the soft tissues - stomatitis, gingivitis, periodontitis, pustular (including acne), rashes, boils, septic wounds and ulcers, and so on.
Often, this drug is prescribed in infectious and inflammatory diseases of the eye - blepharitis and daktiotsistitah.
When vilprafen contraindicated
Vilprafen - a non-toxic drug, therefore, it has a few contraindications for use. This hypersensitivity to the drug by the patient's body and severe liver diseases, which are accompanied by significant impairment of liver function.
In severe renal chronic renal failure vilprafen recommended to be used with caution under the supervision of laboratory tests.
Can vilprafen have side effects?
Maybe, but very rarely. This usually occurs disorders of the gastrointestinal tract - loss of appetite, nausea, vomiting, diarrhea. Dysbacteriosis when taking recommended doses Wilprafen developing very rare, as it only slightly suppresses the natural intestinal microflora. Basically, dysbiosis develops in patients who have pre-treatment and bowel problems. Sometimes it leads to a widening of dysbiosis in the gut fungi of the genus Candida, and the development of intestinal candidiasis.
In rare cases, it develops and liver dysfunction from transient increase in liver enzymes to bile stasis and jaundice. Allergic reactions are also possible.
Vilprafen - a modern, effective and non-toxic antibiotic, which prescribe, however, should the doctor.
Galina Romanenko